Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter's Transformation Requiring Allogeneic Stem Cell Transplantation
Clinical trial NCT03153514 · TERMINATED
Trial details
- NCT number
- NCT03153514
- Sponsor
- German CLL Study Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2019-05-16
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.